share_log

Needham Reiterates Buy on Pliant Therapeutics, Maintains $38 Price Target

Moomoo 24/7 ·  Feb 28 05:28

Needham analyst Joseph Stringer reiterates Pliant Therapeutics (NASDAQ:PLRX) with a Buy and maintains $38 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment